Bell Investment Advisors’s Basel Medical BMGL Stock Holding History

Bell Investment Advisors’s Portfolio BMGL Stock Details BMGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21	Closed	-$122	–	1960
2025 Q4	$122	Hold	21	–	–	﹤0.01%	1789
2025 Q3	$452	Buy	+21	New	+$527	﹤0.01%	1798

Other funds holding BMGL

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

T3 Companies New York $93.7M AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bell Investment Advisors's BMGL Position: Q1 2026 in Review

Bell Investment Advisors sold out of Basel Medical (BMGL) in Q1 2026, closing a stake of 21 shares — an estimated $122 sold.

Bell Investment Advisors first reported a position in BMGL in Q3 2025 and held it in 2 quarters. The position peaked at $452 in Q3 2025. 4 funds tracked by Wall St. Rank hold BMGL as of Q1 2026.

Bell Investment Advisors reported no remaining Basel Medical position as of Q1 2026 after selling out during the quarter.
Bell Investment Advisors sold 21 Basel Medical shares in Q1 2026, an estimated $122.
Bell Investment Advisors first reported a position in Basel Medical in Q3 2025 and held it in 2 quarters.
Bell Investment Advisors's Basel Medical position peaked at $452 in Q3 2025.
4 funds tracked by Wall St. Rank held Basel Medical as of Q1 2026.

Based on Bell Investment Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.